전립선염에 대한 UPOINT 개념의 검토
General Review of UPOINT Concept on Prostatitis
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Traditional approach to manage chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) has not been successful for many patients. There is no one unifying etiological mechanism or specific curative therapy for CP/CPPS. However, each of the proposed mechanisms may be important in some patients, and many of the treatments work in subgroups of patients. So, CP/CPPS patients are not a homogenous group,which suffers from a single disease entity, but rather a heterogeneous group of individual patients with widely different clinical phenotypes. Unique individuals with differing clinical phenotypes based on various etiological mechanisms with distinctive symptom complexes. A clinically practical phenotyping classification system for patients diagnosed with CP/CPPS has recently been proposed and validated in a CP/CPPS cohort. UPOINT is a 6-point clinical classification system that categorizes the phenotype of patients with CP/CPPS into one or more of 6 clinically identifiable domains: urinary, psychosocial, organ specific, infection, neurologic/systemic, and tenderness (muscle). It is proposed that patients be classified into one or more of these phenotypic domains, as a way to characterize them and direct specific therapy. There is a suggestion that phenotypically directed therapy will improve our clinical treatment outcomes.
Abstract
Traditional approach to manage chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) has not been successful for many patients. There is no one unifying etiological mechanism or specific curative therapy for CP/CPPS. However, each of the proposed mechanisms may be important in some patients, and many of the treatments work in subgroups of patients. So, CP/CPPS patients are not a homogenous group,which suffers from a single disease entity, but rather a heterogeneous group of individual patients with widely different clinical phenotypes. Unique individuals with differing clinical phenotypes based on various etiological mechanisms with distinctive symptom complexes. A clinically practical phenotyping classification system for patients diagnosed with CP/CPPS has recently been proposed and validated in a CP/CPPS cohort. UPOINT is a 6-point clinical classification system that categorizes the phenotype of patients with CP/CPPS into one or more of 6 clinically identifiable domains: urinary, psychosocial, organ specific, infection, neurologic/systemic, and tenderness (muscle). It is proposed that patients be classified into one or more of these phenotypic domains, as a way to characterize them and direct specific therapy. There is a suggestion that phenotypically directed therapy will improve our clinical treatment outcomes.
참고문헌 (30)
- Nickel JC, "Failure of a monotherapy strategy for difficult chronic prostatitis", chronic pelvic pain syndrome, 2004, pp.172, 551~554
- Nickel JC, "Phenotypic approach to the management of chronic prostatitis", chronic pelvic pain syndrome, 2009, pp.10, 307~312
- Shoskes DA, "Multimodal therapy for chronic prostatitis", chronic pelvic pain syndrome, 2005, pp.6, 296~299
- Shoskes DA, "Clinical phenotyping of patients with chronic prostatitis", chronic pelvic pain syndrome and correlation with symptom severity, 2009, pp.73, 538~542
- Shoskes DA, "Clinical phenotyping in chronic prostatitis", chronic pelvic pain syndrome and interstitial cystitis: a management strategy for urologic chronic pelvic pain syndromes, 2009, pp.12, 177~183
- Schaeffer AJ, "Chronic prostatitis and chronic pelvic pain syndrome", N Engl J Med, 355, pp.1690~1698 (2006)
- Nickel JC, "Treatment of chronic prostatitis", chronic pelvic pain syndrome, 2008, pp.31, S112~S116
- Nickel JC, "Clinical phenotyping of women with interstitial cystitis", painful bladder syndrome: a key to classification and potentially improved management, 2009, pp.182, 155~160
- Nickel JC, "Psychosocial phenotyping of women with interstitial cystitis", painful bladder syndrome: a case control study, 2010, pp.183, 167~172
- Nickel JC, "Phenotypic approach to the management of the chronic prostatitis", chronic pelvic pain syndrome, 2010, pp.106, 1252~1263
- Staab JP, "Detection and diagnosis of psychiatric disorders in primary medical care settings", Med Clin North Am, 85, pp.579~596 (2001)
- Osman A, "Factor structure, reliability, and validity of the Pain Catastrophizing Scale", J Behav Med, 20, pp.589~605 (1997)
- Anderson RU, "Painful myofascial trigger points and pain sites in men with chronic prostatitis", chronic pelvic pain syndrome, 2009, pp.182, 2753~2758
- Wolfe F, "The American college of rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee", Arthritis Rheum, 33, pp.160~172 (1990)
- Magri V, "Use of the UPOINT chronic prostatitis", chronic pelvic pain syndrome classification in European patient cohorts: sexual function domain improves correlations, 2010, pp.184, 2339~2345
- Hedelin HH, "Evaluation of a modification of the UPOINT clinical phenotype system for the chronic pelvic pain syndrome", Scand J Urol Nephrol, 43, pp.373~376 (2009)
- Nickel JC, "Development of an evidence-based cognitive behavioral treatment program for men with chronic prostatitis", chronic pelvic pain syndrome, 2008, pp.26, 167~172
- Giubilei G, "Physical activity of men with chronic prostatitis", chronic pelvic pain syndrome not satisfied with conventional treatments- could it represent a valid option? The physical activity and male pelvic pain trial: a double- blind, randomized study, 2007, pp.177, 159~165
- Shoskes DA, "Phenotypically directed multimodal therapy for chronic prostatitis", chronic pelvic pain syndrome: a prospective study using UPOINT, 2010, pp.75, 1249~1253
- Shoskes DA, "Quercetin for chronic prostatitis", chronic pelvic pain syndrome, 2011, pp.38, 279~284
- Fall M, "EAU guidelines on chronic pelvic pain", Eur Urol, 57, pp.35~48 (2010)
- Anderson RU, "Integration of myofascial trigger point release and paradoxical relaxation training treatment of chronic pelvic pain in men", J Urol, 174, pp.155~160 (2005)
- Anderson RU, "Sexual dysfunction in men with chronic prostatitis", chronic pelvic pain syndrome: improvement after trigger point release and paradoxical relaxation training, 2006, pp.176, 1534~1538
- Nickel JC, "Failure of a monotherapy strategy for difficult chronic prostatitis", chronic pelvic pain syndrome, 2004, pp.172, 551~554
- Shoskes DA, "Long-term results of multimodal therapy for chronic prostatitis", chronic pelvic pain syndrome, 2003, pp.169, 1406~1410
- Shoskes DA, "Quercetin in men with category III chronic prostatitis: a preliminary prospective, doubleblind, placebo- controlled trial", Urology, 54, pp.960~963 (1999)
- Nickel JC, "Alfuzosin and symptoms of chronic prostatitis- chronic pelvic pain syndrome", N Engl J Med, 359, pp.2663~2673 (2008)
- Lee SW, "Adverse impact of sexual dysfunction in chronic prostatitis", chronic pelvic pain syndrome, 2008, pp.71, 79~84
- Trinchieri A, "Prevalence of sexual dysfunction in men with chronic prostatitis", chronic pelvic pain syndrome, 2007, pp.79, 67~70
- Samplaski MK, "Inclusion of erectile domain to UPOINT phenotype does not improve correlation with symptom severity in men with chronic prostatitis", chronic pelvic pain syndrome, 2011, pp.78, 653~658